Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory CellsMaría Eugenia Dávola, Karen Mossman|Cancers|2023Cited by 13